⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVBP News
ArriVent BioPharma, Inc. Common Stock
Form 8-K
sec.gov
AVBP
ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
globenewswire.com
AVBP
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving ArriVent BioPharma (AVBP)
globenewswire.com
AVBP
AVBP Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into ArriVent BioPharma (AVBP)
accessnewswire.com
AVBP
AVBP Investors with $100,000 in Losses Have Opportunity to Join ArriVent BioPharma, Inc. Fraud Investigation with SBS Law
businesswire.com
AVBP
AVBP Investor Alert: Levi & Korsinsky Investigates ArriVent BioPharma, Inc. (AVBP) For Potential Securities Fraud
accessnewswire.com
AVBP
AVBP Investor Alert: Levi & Korsinsky Investigates ArriVent BioPharma, Inc. (AVBP) for Potential Securities Fraud
accessnewswire.com
AVBP
AVBP SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving ArriVent BioPharma
prnewswire.com
AVBP
AVBP SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates ArriVent BioPharma, Inc. For Possible Securities Law Violations
accessnewswire.com
AVBP
ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
prnewswire.com
AVBP